Trial Profile
Population pharmacokinetics and pharmacodynamics of ramosetron
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 May 2017
Price :
$35
*
At a glance
- Drugs Ramosetron (Primary)
- Indications Postoperative nausea and vomiting
- Focus Pharmacodynamics; Pharmacokinetics
- 07 Sep 2016 New trial record